Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.

<h4>Background</h4>The WHO has issued a call to action urging countries to accelerate the rollout of new WHO-recommended shorter all-oral treatment regimens for drug-resistant TB (DR-TB), which remains a public-health crisis. The all-oral, 6-month BPaL/M regimen comprises 3-4 drugs: pret...

Full description

Bibliographic Details
Main Authors: Aastha Gupta, Sandeep Juneja, Victor Babawale, Nurov Rustam Majidovich, Norbert Ndjeka, Phuong Thi Mai Nguyen, Parpieva Nargiza Nusratovna, David Robert Omanito, Tiffany Tiara Pakasi, Yana Terleeva, Atyrkul Toktogonova, Yasir Waheed, Zaw Myint, Zhao Yanlin, Suvanand Sahu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0296448&type=printable